Cargando…

Optimal chemotherapy treatment for women with recurrent ovarian cancer

QUESTION: What is the optimal chemotherapy treatment for women with recurrent ovarian cancer who have previously received platinum-based chemotherapy? PERSPECTIVES: Currently, standard primary therapy for advanced disease involves a combination of maximal cytoreductive surgery and chemotherapy with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fung-Kee-Fung, M., Oliver, T., Elit, L., Oza, A., Hirte, H.W., Bryson, P.
Formato:	Texto
Lenguaje:	English
Publicado:	Multimed Inc. 2007
Materias:	Practice Guideline Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2002482/ https://www.ncbi.nlm.nih.gov/pubmed/17938703

Ejemplares similares

Cancer antigen 125 in ovarian cancer surveillance: a decision analysis model
por: Hopkins, M.L., et al.
Publicado: (2007)

Adjuvant hormonal therapy for stage I endometrial cancer
por: Gien, L., et al.
Publicado: (2008)

An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline: Consolidation or Maintenance Systemic Therapy for Newly Diagnosed Stage II, III, or IV Epithelial Ovary, Fallopian Tube, or Primary Peritoneal Carcinoma
por: Hirte, Hal, et al.
Publicado: (2021)

Palliative systemic therapy for women with recurrent epithelial ovarian cancer: current options
por: Elit, Laurie, et al.
Publicado: (2013)

Neoadjuvant and Adjuvant Systemic Therapy for Newly Diagnosed Stage II–IV Epithelial Ovary, Fallopian Tube, or Primary Peritoneal Carcinoma: A Practice Guideline
por: Hirte, Hal, et al.
Publicado: (2022)

Optimal use of taxanes in metastatic breast cancer
por: King, K.M., et al.
Publicado: (2009)

Ifosfamide-based combination chemotherapy in advanced soft-tissue sarcoma: a practice guideline
por: Verma, S., et al.
Publicado: (2007)

Dose-intensive chemotherapy with growth factor or autologous bone marrow or stem-cell transplant support in first-line treatment of advanced or metastatic adult soft tissue sarcoma: a clinical practice guideline
por: Verma, S., et al.
Publicado: (2008)

The role of the epidermal growth factor receptor tyrosine kinase inhibitors as therapy for advanced, metastatic, and recurrent non-small-cell lung cancer: a Canadian national consensus statement
por: Ellis, P.M., et al.
Publicado: (2009)

Canadian recommendations for the treatment of glioblastoma multiforme
por: Mason, W.P., et al.
Publicado: (2007)

The role of her2-targeted therapies in women with her2-overexpressing metastatic breast cancer
por: Dent, S., et al.
Publicado: (2009)

Treatment of depression in cancer patients
por: Rodin, G., et al.
Publicado: (2007)

Temozolomide for the treatment of metastatic melanoma
por: Quirbt, I., et al.
Publicado: (2007)

A framework for the organization and delivery of systemic treatment
por: Vandenberg, T., et al.
Publicado: (2009)

Single-agent interleukin-2 in the treatment of metastatic melanoma
por: Petrella, T., et al.
Publicado: (2007)

Gliadel wafers in the treatment of malignant glioma: a systematic review
por: Perry, J., et al.
Publicado: (2007)

Biochemotherapy for the treatment of metastatic malignant melanoma: a clinical practice guideline
por: Verma, S., et al.
Publicado: (2008)

Management of skin rash during egfr-targeted monoclonal antibody treatment for gastrointestinal malignancies: Canadian recommendations
por: Melosky, B., et al.
Publicado: (2009)

Role of oxaliplatin combined with 5-fluorouracil and folinic acid in the first- and second-line treatment of advanced colorectal cancer
por: Jonker, D., et al.
Publicado: (2006)

The 2020 Japan Society of Gynecologic Oncology guidelines for the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer
por: Tokunaga, Hideki, et al.
Publicado: (2021)

Updated recommendations from the Canadian National Consensus Meeting on HER2/neu testing in breast cancer
por: Hanna, W., et al.
Publicado: (2007)

Guidelines for the diagnosis and management of carcinoid tumours. Part 1: The gastrointestinal tract. A statement from a Canadian National Carcinoid Expert Group
por: Maroun, J., et al.
Publicado: (2006)

Canadian supportive care recommendations for the management of anemia in patients with cancer
por: Mikhael, J., et al.
Publicado: (2007)

Alemtuzumab in chronic lymphocytic leukemia
por: Fraser, G., et al.
Publicado: (2007)

Management of single brain metastasis: a practice guideline
por: Mintz, A., et al.
Publicado: (2007)

Canadian supportive care recommendations for the management of neutropenia in patients with cancer
por: Kouroukis, C.T., et al.
Publicado: (2008)

Cardiac management during adjuvant trastuzumab therapy: recommendations of the Canadian Trastuzumab Working Group
por: Mackey, J.R., et al.
Publicado: (2008)

Preparation with recombinant humanized thyroid-stimulating hormone before radioiodine ablation after thyroidectomy: a systematic review
por: Yoo, J., et al.
Publicado: (2009)

(131)I–Tositumomab in lymphoma
por: Cheung, M.C., et al.
Publicado: (2009)

The role of neoadjuvant her2-targeted therapies in her2-overexpressing breast cancers
por: Lemieux, J., et al.
Publicado: (2009)

Colorectal Cancer Association of Canada consensus meeting: raising the standards of care for early-stage rectal cancer
Publicado: (2009)

Clinician–patient communication: evidence-based recommendations to guide practice in cancer
por: Rodin, G., et al.
Publicado: (2009)

Bortezomib in multiple myeloma and lymphoma: a systematic review and clinical practice guideline
por: Reece, D., et al.
Publicado: (2006)

The use of prophylactic anticonvulsants in patients with brain tumours—a systematic review
por: Perry, J., et al.
Publicado: (2006)

Optimizing sodium-glucose co-transporter 2 inhibitor use in patients with heart failure with reduced ejection fraction: A collaborative clinical practice statement
por: Warden, Bruce A., et al.
Publicado: (2021)

Guidelines for the diagnosis and treatment of follicular lymphoma in China
Publicado: (2013)

Guidelines for treatment of renal injury during cancer chemotherapy 2016
por: Horie, Shigeo, et al.
Publicado: (2017)

Multidisciplinary, three-dimensional and individualized comprehensive treatment for severe/critical COVID-19()()
Publicado: (2020)

Japan Society of Gynecologic Oncology 2018 guidelines for treatment of uterine body neoplasms
por: Yamagami, Wataru, et al.
Publicado: (2019)

Cost effectiveness of tac versus fac in adjuvant treatment of node-positive breast cancer
por: Mittmann, N., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_f7jf50ssg1vkckkh6mnuiaiqsp